Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB-IVA cervical cancer
Gynecol Oncol Rep
.
2014 Oct 12:10:36-7.
doi: 10.1016/j.gore.2014.09.002.
eCollection 2014 Dec.
Authors
Narayan Rajan
1
,
Helen Barraclough
1
,
Tarun Puri
2
,
Mauro Orlando
3
Affiliations
1
Eli Lilly Australia, 112 Wharf Rd., West Ryde NSW 2114, Australia.
2
Eli Lilly and Company, Plot. No. 92, Sector 32, Gurgaon 122001, Haryana, India.
3
Eli Lilly Interamerica Inc., Tronador 4890, Piso 12, Buenos Aires 1430, Argentina.
PMID:
26076001
PMCID:
PMC4434144
DOI:
10.1016/j.gore.2014.09.002
No abstract available